- Home
- BRKR vs ARWR Comparison
BRKR vs ARWR Comparison
Compare BRKR & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRKR
- ARWR
- Stock Information
- Founded
- BRKR 1960
- ARWR 2003
- Country
- BRKR United States
- ARWR United States
- Employees
- BRKR N/A
- ARWR N/A
- Industry
- BRKR Biotechnology: Laboratory Analytical Instruments
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- BRKR Industrials
- ARWR Health Care
- Exchange
- BRKR Nasdaq
- ARWR Nasdaq
- Market Cap
- BRKR 5.3B
- ARWR 5.1B
- IPO Year
- BRKR 2000
- ARWR 1993
- Fundamental
- Price
- BRKR $38.72
- ARWR $39.55
- Analyst Decision
- BRKR Buy
- ARWR Strong Buy
- Analyst Count
- BRKR 10
- ARWR 8
- Target Price
- BRKR $49.67
- ARWR $47.75
- AVG Volume (30 Days)
- BRKR 3.2M
- ARWR 1.8M
- Earning Date
- BRKR 11-03-2025
- ARWR 11-25-2025
- Dividend Yield
- BRKR 0.52%
- ARWR N/A
- EPS Growth
- BRKR N/A
- ARWR N/A
- EPS
- BRKR 0.52
- ARWR N/A
- Revenue
- BRKR $3,442,800,000.00
- ARWR $572,976,000.00
- Revenue This Year
- BRKR $4.30
- ARWR $21,287.22
- Revenue Next Year
- BRKR $1.51
- ARWR N/A
- P/E Ratio
- BRKR $74.35
- ARWR N/A
- Revenue Growth
- BRKR 10.36
- ARWR 2816.20
- 52 Week Low
- BRKR $28.53
- ARWR $9.57
- 52 Week High
- BRKR $64.64
- ARWR $40.48
- Technical
- Relative Strength Index (RSI)
- BRKR 61.08
- ARWR 67.43
- Support Level
- BRKR $38.60
- ARWR $36.73
- Resistance Level
- BRKR $41.08
- ARWR $39.56
- Average True Range (ATR)
- BRKR 1.67
- ARWR 1.74
- MACD
- BRKR 0.16
- ARWR -0.20
- Stochastic Oscillator
- BRKR 63.18
- ARWR 84.16
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.